Menu Search
Equities

Syros Pharmaceuticals Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
0LC7:LSE

Syros Pharmaceuticals Inc

Actions
  • Price (USD)0.0002
  • Today's Change0.00 / 0.00%
  • Shares traded243.00
  • 1 Year change-99.89%
  • Beta1.3145
Data delayed at least 20 minutes, as of Feb 13 2026 19:12 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Syros Pharmaceuticals, Inc. is not engaged in any business activities. The Company is actively engaged in the voluntary delisting process. The Company was previously engaged in developing new standards of care for the frontline treatment of patients with hematologic malignancies.

  • Revenue in USD (TTM)386.00k
  • Net income in USD-97.82m
  • Incorporated2011
  • Employees68.00
  • Location
    Syros Pharmaceuticals Inc35 Cambridge Park DriveCAMBRIDGE 02140United StatesUSA
  • Phone+1 (302) 658-7581
  • Fax+1 (302) 655-5049
  • Websitehttps://syros.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.